Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
IS-free Treg HaploHCT
- Status
- RECRUITING
- Phase
- PHASE1
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
- Status
- UNKNOWN
- Phase
- PHASE1
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Status
- RECRUITING
- Phase
- PHASE2
NeoTIL in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
- Status
- RECRUITING
- Phase
- PHASE1
FT819 in Subjects With B-cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CAR-T Cells in Treating Patients With Relapsed or Refractory NHL
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
FT538 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1